Published in Biotechniques on October 01, 1997
The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance. J Bacteriol (2000) 2.51
Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun (1999) 2.42
Optical monitoring and treatment of potentially lethal wound infections in vivo. J Infect Dis (2003) 1.98
Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother (2005) 1.89
The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A (2002) 1.68
Synergistic effects between conventional antibiotics and 2-aminoimidazole-derived antibiofilm agents. Antimicrob Agents Chemother (2010) 1.64
Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother (2006) 1.58
In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect Dis (2011) 1.56
Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials (2006) 1.51
Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun (1999) 1.51
Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun (1999) 1.50
Transcriptional analysis of the Staphylococcus aureus penicillin binding protein 2 gene. J Bacteriol (1998) 1.50
Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod (2007) 1.46
Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med (2007) 1.33
Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother (2004) 1.31
Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother (2005) 1.31
Comparison of three next-generation sequencing platforms for metagenomic sequencing and identification of pathogens in blood. BMC Genomics (2014) 1.30
Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci (2005) 1.29
Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence. Infect Immun (2003) 1.28
Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol (2005) 1.28
Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother (2006) 1.22
Contribution of gelatinase, serine protease, and fsr to the pathogenesis of Enterococcus faecalis endophthalmitis. Infect Immun (2004) 1.21
Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med (2005) 1.15
Internalization of Staphylococcus aureus by human corneal epithelial cells: role of bacterial fibronectin-binding protein and host cell factors. Infect Immun (2002) 1.15
Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant. J Bacteriol (2003) 1.14
The anti-repressor MecR2 promotes the proteolysis of the mecA repressor and enables optimal expression of β-lactam resistance in MRSA. PLoS Pathog (2012) 1.14
Complex role of hemoglobin and hemoglobin-haptoglobin binding proteins in Haemophilus influenzae virulence in the infant rat model of invasive infection. Infect Immun (2006) 1.13
Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria. Lasers Surg Med (2012) 1.11
Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol (2010) 1.11
Effects of endogenous D-alanine synthesis and autoinhibition of Bacillus anthracis germination on in vitro and in vivo infections. Infect Immun (2007) 1.11
Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother (2010) 1.10
Growth, development, and gene expression in a persistent Streptococcus gordonii biofilm. Infect Immun (2003) 1.09
Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother (2008) 1.09
Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) (2010) 1.09
Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother (2011) 1.07
Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother (2012) 1.07
Characterization of three new competence-regulated operons in Haemophilus influenzae. J Bacteriol (2004) 1.06
Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother (2007) 1.05
Methicillin-resistance in Staphylococcus aureus is not affected by the overexpression in trans of the mecA gene repressor: a surprising observation. PLoS One (2011) 1.03
A DNase encoded by integrated element CJIE1 inhibits natural transformation of Campylobacter jejuni. J Bacteriol (2009) 1.03
Antimicrobial blue light therapy for multidrug-resistant Acinetobacter baumannii infection in a mouse burn model: implications for prophylaxis and treatment of combat-related wound infections. J Infect Dis (2013) 1.03
Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol (2005) 1.02
Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg (2013) 1.02
A functional tonB gene is required for both virulence and competitive fitness in a chinchilla model of Haemophilus influenzae otitis media. BMC Res Notes (2012) 1.01
The heme-binding protein (HbpA) of Haemophilus influenzae as a virulence determinant. Int J Med Microbiol (2009) 1.00
Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine (2009) 1.00
Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg Med (2009) 1.00
Revising the role of the pneumococcal vex-vncRS locus in vancomycin tolerance. J Bacteriol (2004) 0.99
Drosophila regulate yeast density and increase yeast community similarity in a natural substrate. PLoS One (2012) 0.97
Nucleases encoded by the integrated elements CJIE2 and CJIE4 inhibit natural transformation of Campylobacter jejuni. J Bacteriol (2009) 0.96
Evernimicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob Agents Chemother (2000) 0.95
Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother (2011) 0.95
Contribution of membrane-damaging toxins to Bacillus endophthalmitis pathogenesis. Infect Immun (2002) 0.95
The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey. Eur J Clin Microbiol Infect Dis (2008) 0.95
Contribution of the nos-pdt operon to virulence phenotypes in methicillin-sensitive Staphylococcus aureus. PLoS One (2014) 0.94
Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections. Antimicrob Agents Chemother (2011) 0.94
Ultraviolet-C light for treatment of Candida albicans burn infection in mice. Photochem Photobiol (2011) 0.94
Multiresistant strains are as susceptible to photodynamic inactivation as their naïve counterparts: protoporphyrin IX-mediated photoinactivation reveals differences between methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains. Photomed Laser Surg (2014) 0.93
Functional characterization of excision repair and RecA-dependent recombinational DNA repair in Campylobacter jejuni. J Bacteriol (2009) 0.93
A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J Infect Chemother (2007) 0.93
Antimicrobial blue light inactivation of Candida albicans: In vitro and in vivo studies. Virulence (2016) 0.93
A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest Ophthalmol Vis Sci (2008) 0.92
Monitoring of bactericidal action of laser by in vivo imaging of bioluminescent E. coli in a cutaneous wound infection. Lasers Med Sci (2006) 0.92
Association between susceptibility to photodynamic oxidation and the genetic background of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2013) 0.92
Synthesis and photodynamic effect of new highly photostable decacationically armed [60]- and [70]fullerene decaiodide monoadducts to target pathogenic bacteria and cancer cells. J Med Chem (2012) 0.90
Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers. J Med Chem (2006) 0.90
Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm. Photochem Photobiol (2010) 0.90
Functional analysis of the glycero-manno-heptose 7-phosphate kinase domain from the bifunctional HldE protein, which is involved in ADP-L-glycero-D-manno-heptose biosynthesis. J Bacteriol (2005) 0.89
The role of the RNA chaperone Hfq in Haemophilus influenzae pathogenesis. BMC Microbiol (2013) 0.89
Antimicrobial photodynamic therapy with fulleropyrrolidine: photoinactivation mechanism of Staphylococcus aureus, in vitro and in vivo studies. Appl Microbiol Biotechnol (2015) 0.88
Molecular investigation of the postantibiotic effects of clarithromycin and erythromycin on Staphylococcus aureus cells. Antimicrob Agents Chemother (1999) 0.88
Optimization of single plate-serial dilution spotting (SP-SDS) with sample anchoring as an assured method for bacterial and yeast cfu enumeration and single colony isolation from diverse samples. Biotechnol Rep (Amst) (2015) 0.88
Ultraviolet C light for Acinetobacter baumannii wound infections in mice: potential use for battlefield wound decontamination? J Trauma Acute Care Surg (2012) 0.87
Thiocyanate potentiates antimicrobial photodynamic therapy: in situ generation of the sulfur trioxide radical anion by singlet oxygen. Free Radic Biol Med (2013) 0.86
UVC light prophylaxis for cutaneous wound infections in mice. Antimicrob Agents Chemother (2012) 0.85
The use of optical fiber in endodontic photodynamic therapy. Is it really relevant? Lasers Med Sci (2012) 0.85
Ultraviolet-C irradiation for prevention of central venous catheter-related infections: an in vitro study. Photochem Photobiol (2010) 0.85
Haemophilus influenzae OxyR: characterization of its regulation, regulon and role in fitness. PLoS One (2012) 0.84
Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm. Pharm Res (2010) 0.84
Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies. Nanomedicine (Lond) (2015) 0.84
A novel conjugative plasmid from Enterococcus faecalis E99 enhances resistance to ultraviolet radiation. Plasmid (2010) 0.84
Tooth-binding micelles for dental caries prevention. Antimicrob Agents Chemother (2009) 0.83
Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress. Photochem Photobiol (2011) 0.83
Ultraviolet C inactivation of dermatophytes: implications for treatment of onychomycosis. Br J Dermatol (2008) 0.83
Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother (2012) 0.83
Prevention of orthopedic device-associated osteomyelitis using oxacillin-containing biomineral-binding liposomes. Pharm Res (2012) 0.82
Unprecedented C-2 arylation of indole with diazonium salts: Syntheses of 2,3-disubstituted indoles and their antimicrobial activity. Bioorg Med Chem Lett (2011) 0.82
Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: in vitro and in vivo studies. Nanomedicine (Lond) (2013) 0.81
Kibdelomycin is a bactericidal broad-spectrum aerobic antibacterial agent. Antimicrob Agents Chemother (2015) 0.81
Redefining the role of the β-lactamase locus in methicillin-resistant Staphylococcus aureus: β-lactamase regulators disrupt the MecI-mediated strong repression on mecA and optimize the phenotypic expression of resistance in strains with constitutive mecA expression. Antimicrob Agents Chemother (2013) 0.81
Rapid Burkholderia pseudomallei identification and antibiotic resistance determination by bacteriophage amplification and MALDI-TOF MS. Bacteriophage (2014) 0.81
An ABC transporter is required for secretion of peptide sex pheromones in Enterococcus faecalis. MBio (2014) 0.81
The vanadyl ribonucleoside complex inhibits ribosomal subunit formation in Staphylococcus aureus. J Antimicrob Chemother (2012) 0.80
Antimicrobial photodynamic inactivation with decacationic functionalized fullerenes: oxygen-independent photokilling in presence of azide and new mechanistic insights. Free Radic Biol Med (2014) 0.80
Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion. Photochem Photobiol Sci (2014) 0.80
A multifunctional peptide based on the neutrophil immune defense molecule, CAP37, has antibacterial and wound-healing properties. J Leukoc Biol (2014) 0.79
Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans. PLoS One (2013) 0.79
Longitudinal study of extended-spectrum-β-lactamase- and AmpC-producing Enterobacteriaceae in household dogs. Antimicrob Agents Chemother (2015) 0.79
Broad-spectrum antimicrobial photocatalysis mediated by titanium dioxide and UVA is potentiated by addition of bromide ion via formation of hypobromite. Free Radic Biol Med (2016) 0.78
Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH. Lasers Surg Med (2011) 0.78
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1989) 7.92
Multiple-drug resistant enterococci: the nature of the problem and an agenda for the future. Emerg Infect Dis (1998) 4.84
Virulence of enterococci. Clin Microbiol Rev (1994) 4.32
Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein. Infect Immun (1999) 3.34
High efficiency introduction of plasmid DNA into glycine treated Enterococcus faecalis by electroporation. Mol Gen Genet (1990) 2.75
Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1991) 2.68
Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun (1992) 2.64
Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun (2001) 2.62
Location of antibiotic resistance determinants, copy control, and replication functions on the double-selective streptococcal cloning vector pGB301. Mol Gen Genet (1981) 2.48
Genetic analysis of the pAD1 hemolysin/bacteriocin determinant in Enterococcus faecalis: Tn917 insertional mutagenesis and cloning. J Bacteriol (1990) 2.20
Plasmid pGB301, a new multiple resistance streptococcal cloning vehicle and its use in cloning of a gentamicin/kanamycin resistance determinant. Mol Gen Genet (1981) 2.14
Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun (1997) 2.13
Clonal associations among Staphylococcus aureus isolates from various sites of infection. Infect Immun (2001) 2.08
Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic. Mol Microbiol (1996) 1.71
Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci (1995) 1.58
PCR amplification of streptococcal DNA using crude cell lysates. FEMS Microbiol Lett (1992) 1.55
Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine (Baltimore) (1994) 1.54
Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun (1999) 1.51
Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun (1999) 1.50
Infections with Ehrlichia chaffeensis and Ehrlichia ewingii in persons coinfected with human immunodeficiency virus. Clin Infect Dis (2001) 1.49
Extracellular superoxide production by Enterococcus faecalis requires demethylmenaquinone and is attenuated by functional terminal quinol oxidases. Mol Microbiol (2001) 1.39
In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens. Cornea (2000) 1.38
A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis. Invest Ophthalmol Vis Sci (1992) 1.37
Identification of aerobically and anaerobically induced genes in Enterococcus faecalis by random arbitrarily primed PCR. Appl Environ Microbiol (1999) 1.32
Molecular characterization of the Enterococcus faecalis cytolysin activator. Infect Immun (1991) 1.30
Effects of amino acids on expression of enterococcal vancomycin resistance. Antimicrob Agents Chemother (1992) 1.21
Identification of members of the Burkholderia cepacia complex by species-specific PCR. J Clin Microbiol (2000) 1.21
Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci (1995) 1.20
N-Halo derivatives V: Comparative antimicrobial activity of soft N-chloramine systems. J Pharm Sci (1976) 1.19
Electroporation and efficient transformation of Enterococcus faecalis grown in high concentrations of glycine. Methods Mol Biol (1995) 1.13
A novel human airway mucin cDNA encodes a protein with unique tandem-repeat organization. Biochem J (1994) 1.12
Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus. Am J Respir Cell Mol Biol (1997) 1.11
Frequency of aggregation substance and cytolysin genes among enterococcal endocarditis isolates. Plasmid (1995) 1.08
Completion of the nucleotide sequence of the Enterococcus faecalis conjugative virulence plasmid pAD1 and identification of a second transfer origin. Plasmid (2001) 1.07
Multilocus sequence typing and analysis of putative virulence factors in vancomycin-resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil. Clin Microbiol Infect (2006) 1.07
Molecular epidemiology of Staphylococcus aureus and Enterococcus faecalis in endophthalmitis. Infect Immun (1998) 1.03
Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm (2000) 1.02
The growth-inhibitory effect of the Enterococcus faecalis bacteriocin encoded by pAD1 extends to the oral streptococci. J Dent Res (1990) 1.01
Molecular cloning of genes encoding gram-positive virulence factors. Curr Top Microbiol Immunol (1985) 0.98
Characterization of the Enterococcus faecalis alpha C protein homolog. Evidence for the expression of alternate forms in commensal and infection derived isolates. Adv Exp Med Biol (1997) 0.97
Molecular nature of a novel bacterial toxin: the cytolysin of Enterococcus faecalis. Med Microbiol Immunol (1999) 0.96
Enterococcus faecalis localization in experimental endophthalmitis: role of plasmid-encoded aggregation substance. Infect Immun (1998) 0.96
Identification of a p28 gene in Ehrlichia ewingii: evaluation of gene for use as a target for a species-specific PCR diagnostic assay. J Clin Microbiol (2001) 0.95
In vivo survival of Enterococcus faecalis is enhanced by extracellular superoxide production. Adv Exp Med Biol (1997) 0.95
Transfer of pheromone-inducible plasmids between Enterococcus faecalis in the Syrian hamster gastrointestinal tract. J Infect Dis (1992) 0.94
Apophysomyces elegans infection in a renal transplant recipient. Am J Kidney Dis (1995) 0.93
Transferability and genetic relatedness of high-level gentamicin resistance among enterococci. Antimicrob Agents Chemother (1994) 0.92
A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin. Infect Immun (1999) 0.92
The descriptive epidemiology of Lyme disease in Oklahoma. J Okla State Med Assoc (1991) 0.92
Antibiotic resistance. A vancomycin surprise. Nature (1999) 0.89
Host/parasite interactions in bacterial endophthalmitis. Zentralbl Bakteriol (1997) 0.89
Molecular cloning of the carboxy terminus of a canine tracheobronchial mucin. Biochem Biophys Res Commun (1992) 0.87
Prospective case-cohort study of intestinal colonization with enterococci that produce extracellular superoxide and the risk for colorectal adenomas or cancer. Am J Gastroenterol (1998) 0.85
A hospital-based pharmacy intervention program for pneumococcal vaccination. Arch Intern Med (1998) 0.84
Identification of a highly conserved lipopolysaccharide (LPS) modification operon in Enterococcus faecalis. Adv Exp Med Biol (1997) 0.83
Characteristics of potential plaintiffs in malpractice litigation. Ann Intern Med (1994) 0.81
Human B cell lines can be triggered to secrete an interleukin 2-like molecule. Cell Immunol (1989) 0.80
Enterococcus faecalis cytolysin without effect on the intestinal growth of susceptible enterococci in mice. J Infect Dis (1995) 0.80
Colitis due to antituberculous chemotherapy. South Med J (1991) 0.80
Disseminated histoplasmosis mimicking Crohn's disease in a patient with the acquired immunodeficiency syndrome. Am J Gastroenterol (1994) 0.80
Phages and other mobile virulence elements in gram-positive pathogens. Curr Top Microbiol Immunol (2002) 0.78
Nucleotide sequence of a cDNA for canine beta-spectrin reveals high evolutionary conservation. Biochim Biophys Acta (1993) 0.77
The Enterococcus faecalis cytolysin determinant and its relationship to those encoding lantibiotics. Dev Biol Stand (1995) 0.77
Outbreak of pseudobacteremia due to multidrug-susceptible Enterococcus faecium. Clin Infect Dis (1999) 0.76
Enterococcus: an old pathogen with new tricks. J Okla State Med Assoc (1991) 0.76
Virulence factors in vancomycin-resistant and vancomycin- susceptible Enterococcus faecalis from Brazil. Braz J Microbiol (2008) 0.76
Identification of virulence genes in Enterococcus faecalis by differential display polymerase chain reaction. Adv Exp Med Biol (1997) 0.75
Further evidence that the human MUC2 gene transcripts in the intestine and trachea are identical. Biochem J (1995) 0.75
Corticosteroid and antibiotic therapy for bacillus endophthalmitis. Arch Ophthalmol (2001) 0.75
Clinical experience with HIV-infected patients at the University of Oklahoma Health Sciences Center: an update. J Okla State Med Assoc (1993) 0.75
High-level gentamicin resistance among enterococci. Dev Biol Stand (1995) 0.75
Frequency of aggregation substance and cytolysin genes among enterococcal endocarditis isolates. Dev Biol Stand (1995) 0.75
Lyme disease now reportable in Oklahoma, letter reminds MDs. J Okla State Med Assoc (1991) 0.75
A leukemoid reaction caused by a nasal sympathomimetic. Clin Infect Dis (1992) 0.75
Translation of messenger RNA from canine tracheal epithelial cells: identification of mucin core protein. Am J Respir Cell Mol Biol (1991) 0.75
Surgical Infection Society position on vancomycin-resistant Enterococcus. Arch Surg (1996) 0.75